Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics

Fertility and Sterility

Volumn 90, Issue 5, 2008, Pages 1892-1898

  Lv, Jieqiang ^a   Zhu, Xueqiong ^a   Dong, Ke ^a   Lin, Yi ^a   Hu, Yue ^a   Zhu, Chundan ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

14 3 3 gamma; immunohistochemistry; Leiomyoma; myometrium; RT PCR; tandem mass spectrometry; two dimensional gel electrophoresis; Western blot

Indexed keywords

14 3 3 PROTEIN GAMMA; ALPHA 1 ANTITRYPSIN; CELL PROTEIN; DERMCIDIN; DESMIN; LIPOCORTIN 1; LUMICAN; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MYOMETRIUM; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUMOR GROWTH; TWO DIMENSIONAL ELECTROPHORESIS; UTERUS BIOPSY; UTERUS MYOMA; WESTERN BLOTTING;

14-3-3 PROTEINS; BLOTTING, WESTERN; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MYOMETRIUM; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TANDEM MASS SPECTROMETRY; UTERINE NEOPLASMS;

EID: 55149120989     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.08.039     Document Type: Article

References (29)

1. Day Baird D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188 (2003) 100-107
2. Farquhar C.M., and Steiner C.A. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 99 (2002) 229-234
3. Subramanian S., Clark M.A., and Isaacson K. Outcome and resource use associated with myomectomy. Obstet Gynecol 98 (2001) 583-587
4. Pambuccian C.A., Oprea G.M., and Lakatua D.J. Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display. Gynecol Oncol 84 (2002) 431-436
5. Wu X., Blanck A., Norstedt G., Sahlin L., and Flores-Morales A. Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium. Mol Hum Reprod 8 (2002) 246-254
6. Li B., and Zhang Y.L. Identification of up-regulated genes in human uterine leiomyoma by suppression subtractive hybridization. Cell Res 12 (2002) 215-221
7. Tsibris J.C., Segars J., Coppola D., Mane S., Wilbanks G., O'Brien W.F., et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78 (2002) 114-121
8. Lee E.J., Kong G., Lee S.H., Rho S.B., Park C.S., Kim B.G., et al. Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer 15 (2005) 146-154
9. Roth T.M., Klett C., and Cowan B.D. Expression profile of several genes in human myometrium and uterine leiomyoma. Fertil Steril 87 (2007) 635-641
10. Catherino W.H., Prupas C., Tsibris J.C., Leppart P.C., Payson M., Nieman L.K., et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 80 (2003) 282-290
11. Moseley F.L., Bicknell K.A., Marber M.S., and Brooks G. The use of proteomics to identify novel therapeutic targets for the treatment of disease. J Pharm Pharmacol 59 (2007) 609-628
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
13. Gorg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
14. Kavallaris M., and Marshall G.M. Proteomics and disease: opportunities and challenges. Med J Aust 182 (2005) 575-579
15. Zhang H., Niu Y., Feng J., Guo H., Ye X., and Cui H. Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls. Fertil Steril 86 (2006) 274-282
16. Wilker E., and Yaffe M.B. 14-3-3 proteins-a focus on cancer and human disease. J Mol Cell Cardiol 37 (2004) 633-642
17. Tzivion G., Gupta V.S., Kaplun L., and Balan V. 14-3-3 proteins as potential oncogenes. Semin Cancer Biol 16 (2006) 203-213
18. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 3 (2003) 931-943
19. Jin Y., Dai M.S., Lu S.Z., Xu Y., Luo Z., Zhao Y., et al. 14-3-3 gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 25 (2006) 1207-1218
20. Gasco M., Sullivan A., Repellin C., Brooks L., Farrell P.J., Tidy J.A., et al. Coincident inactivation of 14-3-3 sigma and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 21 (2002) 1876-1881
21. Moreira J.M., Gromov P., and Celis J.E. Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics 3 (2004) 410-419
22. Simooka H., Oyama T., Sano T., Horiguchi J., and Nakajima T. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int 54 (2004) 595-602
23. Gasco M., Bell A.K., Heath V., Sullivan A., Smith P., Hiller L., et al. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16 (INK4a) silencing and human papillomavirus negativity. Cancer Res 62 (2002) 2072-2076
24. Somiari R.I., Somiari S., Russell S., and Shriver C.D. Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 815 (2005) 215-225
25. Arora S., Matta A., Shukla N.K., Deo S.V., and Ralhan R. Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog 42 (2005) 97-108
26. Jang J.S., Cho H.Y., Lee Y.J., Ha W.S., and Kim H.W. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14 (2004) 491-499
27. Qi W., Liu X., Qiao D., and Martinez J.D. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113 (2005) 359-363
28. Castagna A., Antonioli P., Astner H., Hamdan M., Righetti S.C., Perego P., et al. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 4 (2004) 3246-3267
29. Bifulco G., Miele C., Pellicano M., Trencia A., Ferraioli M., Paturzo F., et al. Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas. Mol Hum Reprod 10 (2004) 43-48